• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»SARS- CoV2 & COVID-19 Updates»Do not Push COVID vaccine for Children, trial size is laughable, says Experts

Do not Push COVID vaccine for Children, trial size is laughable, says Experts

0
By Biotech Express on November 30, 2021 SARS- CoV2 & COVID-19 Updates

Global evidence available so far has suggested that the Sars CoV-2 virus that causes Covid-19 has infected kids but it hasn’t caused any severity among them. The mortality rate is as low as two children per 10 lakh. However, in India, the government hasn’t released any data (like other COVID data) on the mortality of children due to Covid-19 in both the first and the second waves.

The seroprevalence survey conducted in various parts of the country including Delhi has also shown that 70 per cent to 90 per cent of kids have already been exposed to the virus and they have developed natural antibodies.

Dr Amitav Banerjee, Clinical epidemiologist, In Dr D Y Patil Medical College, Pune, points out physiological as well as epidemiological evidence which suggests that kids don’t need vaccines. “They have very well-developed thymus glands which produce very good T-Cell and memory cell immunity. They also lack ACE-2 receptors on which the spike protein of the virus latches in the lungs,” Dr Banerjee said. He added, “Also, they have got a very high melatonin level that is very protective against the virus. So physiologically they are very well-protected by the nature.” ” , said.

Experts like Dr Sanjay K Rai, Professor, Centre for Community Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi and Dr Jayaprakash Muliyil, who is chairman of the Scientific Advisory Committee of the National Institute of Epidemiology, are of the view that the risk of Adverse Event Following Immunization (AEFI) is very low but it is not zero at all. “In such scenarios, we should look at a comparative picture of risk from Covid-19 as well as AEFI. If the latter outweighs the former, then vaccination is a costly and risky exercise with no benefits,” Dr Rai said.

Dr Muliyil also feels that the death among kids, especially below 12, is almost zero and “there is no reason to vaccinate kids as they are not vulnerable to Covid-19,” he said.

Dr Banerjee seconds the view that the vaccine’s side effect is not negligible. “There has been adverse effect from the vaccine particularly Myocarditis after the launch of vaccinations for children in some countries,” he said. Once the mass vaccination process started, countries reported several types of side effects, including changes to women’s menstrual cycles in the UK and blood clotting from the AstraZeneca (Covishield) vaccine among others. In April 2021, various European countries restricted the use of AstraZeneca (Covishield); it is not recommended for the young, based on safety concerns.

Bhaskaran Raman, a faculty in the Department of Computer Science and Engineering at IIT Bombay, said, “Data from various countries such as the USA, Israel, and Canada show that this risk of Myocarditis to kids from the mRNA vaccine is about 1 in 6000. Considering this, many European countries recently stopped the use of the Moderna vaccine for those under 30,”. Raman has been carrying out a data study of various countries on the impact of vaccination. He said, “It is important to note here that the above risks were not signalled in the initial vaccine trials: the trial size itself was too small to uncover rare risks (32,449 for AstraZeneca/Covishield). That these risks have been found after mass vaccination is deeply concerning.”

He added, “The trial sizes for kids’ vaccines (525: Covaxin, 1000: ZyCov-D), are laughably small, except that this is no laughing matter. Such low trial sizes cannot capture anything but the most obvious risks. Would we discover other risks of Covaxin or ZyCov-D after vaccinating millions of children? This is a very worrying unknown indeed.”

Raman in his data research has found that in the USA, for kids aged 5-14, Covid represents a lower risk than each of the following: flu/pneumonia, drowning, heart disease, homicide, suicide, traffic accidents, and cancer.

“In the context of India, other comparisons are even starker: nearly 9 lakh children die of hunger-related causes every year. Almost 2000 infants die every single day in India, of preventable malnutrition-related causes: infant mortality rate of nearly 3% is about 1000-2000 times more than the risk of Covid death for kids!” Raman said.

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Researchers who jumped into the field from distant disciplines published lower impact work, study finds

Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.